NCT03718676 is a NA clinical trial of Ferric sulphate in Pulpotomy, sponsored by Aydin Adnan Menderes University.

Who is sponsoring NCT03718676?

NCT03718676 is sponsored by Aydin Adnan Menderes University.

What drugs are being tested in NCT03718676?

Interventions in NCT03718676: Ferric sulphate, Ortho-MTA, Retro-MTA.

Is NCT03718676 still recruiting?

NCT03718676 is currently completed. Last updated 5 March 2019.

Last reviewed 2019-03-05 · How we verify

NCT03718676

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pulpotomy With Various MTA Materials and Ferric Sulphate

Completed NA Last updated 5 March 2019

What this trial tests

NA trial testing Ferric sulphate in Pulpotomy in 32 participants. Completed in 30 December 2018.

Timeline

2 June 2017

Primary endpoint
30 June 2018

30 December 2018

Quick facts

Lead sponsor	Aydin Adnan Menderes University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	32
Start date	2 June 2017
Primary completion	30 June 2018
Estimated completion	30 December 2018
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Ferric sulphate
Ortho-MTA
Retro-MTA

Conditions studied

Pulpotomy — all drugs for Pulpotomy →

Sponsor

Aydin Adnan Menderes University

Who can join

Adults 5 to 9, any sex, with Pulpotomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to determine clinical and radiographic efficacy of the newly developed OrthoMTA and RetroMTA , compared frequently used ferric sulfate for pulpotomy in primary second molars.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy of orthoMTA, retroMTA and ferric sulphate as pulpotomy agents in primary molars: a randomized clinical trial.
Yilmaz S, Keles S. · · 2023 · cited 3× · PMID 37929220 · DOI 10.26650/eor.2023950004

Verify or expand the search:

Other trials of Ferric sulphate

Trials testing the same drug.

NCT07324928 — Effect of Ferric Sulphate and Putty MTA as Pulpotomy Agent in Vital Primary Teeth · NA · enrolling by invitation

Other recruiting trials for Pulpotomy

Currently open trials in the same condition.

NCT06685640 — Comparison of Clinical Success of Stainless Steel Crowns and Zirconia Crowns in Primary Molars · NA · recruiting
NCT06288477 — Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Biocera · NA · recruiting
NCT06640205 — Assessment of I-PRF Versus Nano MTA Combined with I-PRF Scaffold in Vital Pulp Therapy in Mature Mandibular First Molars · NA · recruiting
NCT04863222 — Clinical and Radiographic Success of MTA vs Biodentine · Phase 4 · recruiting
NCT02298504 — Vital Pulp Treatment in Primary Teeth · Phase 4 · active not recruiting

Other Aydin Adnan Menderes University trials

Trials by the same sponsor.

NCT07535151 — The Study Aims to Determine the Effect of Using Animal-shaped Magic Mirrors During Vaccination in Children Aged 1-4 Year · not yet recruiting
NCT07448246 — Effect of Bilateral Rhomboid Intercostal Block on Postoperative Pain After Breast Implant Surgery · NA · recruiting
NCT07317492 — HEMOVAR Study on Hemorrhoids and Varicose Veins · recruiting
NCT07121699 — The Role of Left Ventricular Outflow Tract (LVOT) Velocity-time Integral (VTI) and Respiratory Variability at Peak Rate · not yet recruiting
NCT07044739 — Information on the Use of Anti-embolic Stockings in Patients Undergoing Vein Surgery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03718676 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aydin Adnan Menderes University
Last refreshed: 5 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03718676.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing